Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor

MLA

Heribert Bohlen, et al. “Elevated Serum Levels of CC Thymus and Activation-Related Chemokine (TARC) in Primary Hodgkin’s Disease: Potential for a Prognostic Factor.” Cancer Research, vol. 65, no. 13, July 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fa84ab8019d68419838b875fb4457eba&authtype=sso&custid=ns315887.

APA

Heribert Bohlen, Marc Beyer, Volker Diehl, Martin R. Weihrauch, Joachim L. Schultze, Juergen Wolf, Heinz Haverkamp, & Oliver Manzke. (2005). Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin’s disease: potential for a prognostic factor. Cancer Research, 65(13).

Chicago

Heribert Bohlen, Marc Beyer, Volker Diehl, Martin R. Weihrauch, Joachim L. Schultze, Juergen Wolf, Heinz Haverkamp, and Oliver Manzke. 2005. “Elevated Serum Levels of CC Thymus and Activation-Related Chemokine (TARC) in Primary Hodgkin’s Disease: Potential for a Prognostic Factor.” Cancer Research 65 (13). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fa84ab8019d68419838b875fb4457eba&authtype=sso&custid=ns315887.